$2.10
+0.48%Price chart
Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29
Key dataOct 29, 2026
Open$2.09
From 52W high−90.67%
Volume4556.00
Market cap$17.84M
P/E (TTM)—
P/S (TTM)0.6x
Div yield—
Key dataOct 29, 2026
Open
$2.09
From 52W high
−90.67%
Volume
4556.00
Market cap
$17.84M
ValuationView details →
P/E (Fwd)
7.4x
EV/EBITDA
−0.3x
P/E (TTM)
—
RSI (14)
15.9
MomentumView details →
1D Return
+0.48%
YTD Return
−83.05%
SummaryUpdated Jun 1, 2026
Scilex Holding Company (NASDAQ:SCLX) is a biopharmaceutical company founded in 2016 and publicly traded since March 2021. Based in Palo Alto, California, the company operates as a subsidiary of Sorrento Therapeutics and focuses on developing and commercializing non-opioid pain management solutions. Scilex addresses the critical healthcare challenge of treating acute and chronic pain without contributing to the opioid crisis that has plagued the United States for decades.
Similar companies
Latest newsMore news →
DataMeds AI, Inc. signed a letter of intent to acquire QLPM intellectual property assets from EOS Technology Holdings and Scilex Holding Co, acquire a controlling interest in HealthBridge Advisors, LLC and Tollo Health, Inc. through an exchange of membership interests, and enter related licensing and services arrangements, with consideration in DataMeds common shares.1d agoSCIENTURE announced that its Arbli product has been added to the formularies at three leading U.S. pediatric academic medical centers and hospitals.27d agoDataMeds AI announced the pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate intellectual properties and deliver the 'Health Lives Here' consumer app in partnership with NFL Alumni Health.73d ago